333 related articles for article (PubMed ID: 33478398)
1. Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters.
Lei C; Zhu X; Hsi DH; Wang J; Zuo L; Ta S; Yang Q; Xu L; Zhao X; Wang Y; Sun S; Liu L
BMC Cardiovasc Disord; 2021 Jan; 21(1):43. PubMed ID: 33478398
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic study.
Pradel S; Magne J; Jaccard A; Fadel BM; Boulogne C; Salemi VMC; Damy T; Aboyans V; Mohty D
Int J Cardiovasc Imaging; 2019 May; 35(5):845-854. PubMed ID: 30623354
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation.
Pun SC; Landau HJ; Riedel ER; Jordan J; Yu AF; Hassoun H; Chen CL; Steingart RM; Liu JE
J Am Soc Echocardiogr; 2018 Jan; 31(1):64-70. PubMed ID: 29111123
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers.
Buss SJ; Emami M; Mereles D; Korosoglou G; Kristen AV; Voss A; Schellberg D; Zugck C; Galuschky C; Giannitsis E; Hegenbart U; Ho AD; Katus HA; Schonland SO; Hardt SE
J Am Coll Cardiol; 2012 Sep; 60(12):1067-76. PubMed ID: 22883634
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional Speckle Tracking Echocardiography in Light Chain Cardiac Amyloidosis: Examination of Left and Right Ventricular Myocardial Mechanics Parameters.
Urbano-Moral JA; Gangadharamurthy D; Comenzo RL; Pandian NG; Patel AR
Rev Esp Cardiol (Engl Ed); 2015 Aug; 68(8):657-64. PubMed ID: 26092748
[TBL] [Abstract][Full Text] [Related]
7. Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis.
Ochs MM; Fritz T; Arenja N; Riffel J; Andre F; Mereles D; Siepen FAD; Hegenbart U; Schönland S; Katus HA; Friedrich MGW; Buss SJ
J Cardiovasc Magn Reson; 2017 Nov; 19(1):87. PubMed ID: 29121956
[TBL] [Abstract][Full Text] [Related]
8. Value of tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain on predicting outcome of patients with light-chain cardiac amyloidosis.
Liu D; Hu K; Herrmann S; Cikes M; Ertl G; Weidemann F; Störk S; Nordbeck P
Int J Cardiovasc Imaging; 2017 Jun; 33(6):837-845. PubMed ID: 28265790
[TBL] [Abstract][Full Text] [Related]
9. A new staging system using right atrial strain in patients with immunoglobulin light-chain cardiac amyloidosis.
Usuku H; Yamamoto E; Sueta D; Shinriki R; Oike F; Tabata N; Ishii M; Hanatani S; Hoshiyama T; Kanazawa H; Arima Y; Takashio S; Kawano Y; Oda S; Kawano H; Ueda M; Tsujita K
ESC Heart Fail; 2024 Jun; 11(3):1612-1624. PubMed ID: 38400613
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.
Kristen AV; Rosenberg M; Lindenmaier D; Merkle C; Steen H; Andre F; Schönland SO; Schnabel PA; Schuster T; Röcken C; Giannitsis E; Katus HA; Frey N
Amyloid; 2014 Sep; 21(3):202-10. PubMed ID: 25007036
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis.
Arenja N; Andre F; Riffel JH; Siepen FAD; Hegenbart U; Schönland S; Kristen AV; Katus HA; Buss SJ
J Cardiovasc Magn Reson; 2019 Aug; 21(1):53. PubMed ID: 31434577
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of strain Doppler imaging in light-chain amyloidosis.
Koyama J; Falk RH
JACC Cardiovasc Imaging; 2010 Apr; 3(4):333-42. PubMed ID: 20394893
[TBL] [Abstract][Full Text] [Related]
14. Utility of B-Type Natriuretic Peptide for Detecting Cardiac Involvement in Immunoglobulin Amyloidosis.
Kimishima Y; Yoshihisa A; Kiko T; Yokokawa T; Miyata-Tatsumi M; Misaka T; Oikawa M; Kobayashi A; Takeishi Y
Int Heart J; 2019 Sep; 60(5):1106-1112. PubMed ID: 31484874
[TBL] [Abstract][Full Text] [Related]
15. Impact of monitoring longitudinal systolic strain changes during serial echocardiography on outcome in patients with AL amyloidosis.
Hu K; Liu D; Nordbeck P; Cikes M; Störk S; Kramer B; Gaudron PD; Schneider A; Knop S; Ertl G; Bijnens B; Weidemann F; Herrmann S
Int J Cardiovasc Imaging; 2015 Oct; 31(7):1401-12. PubMed ID: 26179863
[TBL] [Abstract][Full Text] [Related]
16. Role of Right Ventricular Strain Measured by Two-Dimensional Echocardiography in the Diagnosis of Cardiac Amyloidosis.
Moñivas Palomero V; Durante-Lopez A; Sanabria MT; Cubero JS; González-Mirelis J; Lopez-Ibor JV; Navarro Rico SM; Krsnik I; Dominguez F; Mingo AM; Hernandez-Perez FJ; Cavero G; Santos SM
J Am Soc Echocardiogr; 2019 Jul; 32(7):845-853.e1. PubMed ID: 31078369
[TBL] [Abstract][Full Text] [Related]
17. Clinical and imaging characteristics of patients with cardiac amyloidosis- a single center observational study.
Ingebrigtsen A; Saeed S; Larsen TH; Reikvam H
Scand J Clin Lab Invest; 2024 May; 84(3):193-201. PubMed ID: 38709651
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular myocardial work improves in response to treatment and is associated with survival among patients with light chain cardiac amyloidosis.
Briasoulis A; Bampatsias D; Petropoulos I; Rempakos A; Patras R; Theodorakakou F; Makris N; Dimopoulos MA; Stamatelopoulos K; Kastritis E
Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):698-707. PubMed ID: 38142437
[TBL] [Abstract][Full Text] [Related]
19. Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis.
Kim D; Lee GY; Choi JO; Kim K; Kim SJ; Jeon ES
Sci Rep; 2019 May; 9(1):7746. PubMed ID: 31123293
[TBL] [Abstract][Full Text] [Related]
20. [The importance of cardiac bio-marker assay for the stratification and monitoring of AL amyloidosis patients - single center experience].
Pika T; Lochman P; Vymětal J; Metelka R; Flodr P; Minařík J; Látalová P; Zapletalová J; Bačovský J; Sčudla V
Vnitr Lek; 2013 Sep; 59(9):776-81. PubMed ID: 24073949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
